Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia

Research output: Contribution to journalArticlepeer-review

57 Scopus citations


Equine malignant hyperthermia (MH) has been suspected but never genetically confirmed. In this study, we investigated whether mutations in a candidate gene, RyR1, were associated with MH in two clinically affected horses. RyR1 gene sequences revealed polymorphisms in exons 15, 17, and 46 in WTRyR1 and MHRyR1 horses with one derived amino acid change in MHRyR1 exon 46, R2454G. The MHRyR1 horses were genetically heterozygous for this mutation, but presented an MH phenotype with halothane challenge. Skeletal sarcoplasmic reticulum from a R2454G heterozygote collected during a fulminant MH episode showed significantly higher affinity and density of [3H]ryanodine-binding sites compared to WTRyR1, but no differences in Ca2+, Mg2+, and caffeine modulation. In conclusion, an autosomal missense mutation in RyR1 is associated with MH in the horse, providing a screening test for susceptible individuals. [ 3H]ryanodine-binding analysis suggests that long-lasting changes in RyR1 conformation persists in vitro after the triggering event.

Original languageEnglish (US)
Pages (from-to)356-365
Number of pages10
JournalMuscle and Nerve
Issue number3
StatePublished - Sep 2004


  • Equine
  • Halothane
  • Malignant hyperthermia
  • Rhabdomyolysis
  • Ryanodine receptor 1
  • Sarcoplasmic reticulum

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)


Dive into the research topics of 'Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia'. Together they form a unique fingerprint.

Cite this